Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death
worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol …

The use of biomarkers as early warning systems in the evaluation of disease risk has
increased markedly in the last decade. Biomarkers are indicators of typical biological …

This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …

The incidence of hepatocellular carcinoma (HCC) has been rising worldwide over the last
20 years and is expected to increase until 2030 in some countries including the United …

Hepatocellular carcinoma (HCC) is one of the main cancer-related causes of death
worldwide. Thus, there is a constant search for improvement in screening, diagnosis, and …

Evidence-based management of patients with hepatocellular carcinoma (HCC) is key to
their optimal care. For individuals at risk for HCC, surveillance usually involves …

Background & Aims The success of direct-acting antivirals (DAA) against hepatitis C is a
major breakthrough in hepatology. Until now, however, there are very few data on the effect …

The intent of CAD-RADS–Coronary Artery Disease Reporting and Data System is to create a
standardized method to communicate findings of coronary CT angiography (coronary CTA) …

One of the key strategies to improve the prognosis of HCC, beside prevention, is to diagnose
the tumor in early stages, when the patient is asymptomatic and the liver function is …

Objectives To develop and validate a proof-of-concept convolutional neural network (CNN)–
based deep learning system (DLS) that classifies common hepatic lesions on multi-phasic …